• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在自然感染和接种人巨细胞病毒疫苗后,均会出现针对人巨细胞病毒糖蛋白B的黏膜抗体。

Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines.

作者信息

Wang J B, Adler S P, Hempfling S, Burke R L, Duliège A M, Starr S E, Plotkin S A

机构信息

Department of Pediatrics, Medical College of Virginia, Richmond 23298-0163, USA.

出版信息

J Infect Dis. 1996 Aug;174(2):387-92. doi: 10.1093/infdis/174.2.387.

DOI:10.1093/infdis/174.2.387
PMID:8699071
Abstract

Because antibodies against human cytomegalovirus (HCMV) glycoprotein B (gB) neutralize, levels of IgG, secretory IgA (sIgA), and mucosal IgA1 antibodies to HCMV were measured in saliva and nasal washes. Ten seronegative adults lacked these antibodies, but of 10 naturally seropositive adults, 10 had IgG to gB, 5 had sIgA, and 0 had mucosal IgA. Among 12 recipients of a live HCMV vaccine, 8 had IgG to gB, 4 had sIgA, and 2 had mucosal IgA in samples collected 10-20 months after immunization; of 10 recipients of a gB vaccine, 8 had IgG to gB, 7 had sIgA, and 7 had mucosal IgA in samples collected just before or 1 month after a booster. IgG to gB and neutralizing titers in serum correlated with IgG to gB in mucosal samples. IgG to gB was in the saliva of 25 of 26 subjects with serum neutralizing titers > 1:64. Serum neutralizing titers > 1:64, whether induced by vaccine or wild type virus, are associated with mucosal IgG to HCMV.

摘要

由于抗人巨细胞病毒(HCMV)糖蛋白B(gB)的抗体具有中和作用,因此对唾液和鼻腔灌洗液中针对HCMV的IgG、分泌型IgA(sIgA)和黏膜IgA1抗体水平进行了检测。10名血清阴性的成年人缺乏这些抗体,但在10名自然血清阳性的成年人中,10人有针对gB的IgG,5人有sIgA,0人有黏膜IgA。在12名接种活HCMV疫苗的受种者中,免疫后10 - 20个月采集的样本中,8人有针对gB的IgG,4人有sIgA,2人有黏膜IgA;在10名接种gB疫苗的受种者中,加强免疫前或加强免疫后1个月采集的样本中,8人有针对gB的IgG,7人有sIgA,7人有黏膜IgA。血清中针对gB的IgG和中和滴度与黏膜样本中针对gB的IgG相关。26名血清中和滴度>1:64的受试者中,25人的唾液中有针对gB的IgG。血清中和滴度>1:64,无论由疫苗还是野生型病毒诱导,均与针对HCMV的黏膜IgG相关。

相似文献

1
Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines.在自然感染和接种人巨细胞病毒疫苗后,均会出现针对人巨细胞病毒糖蛋白B的黏膜抗体。
J Infect Dis. 1996 Aug;174(2):387-92. doi: 10.1093/infdis/174.2.387.
2
IgA binds to the AD-2 epitope of glycoprotein B and neutralizes human cytomegalovirus.IgA 与糖蛋白 B 的 AD-2 表位结合并中和人巨细胞病毒。
Immunology. 2021 Mar;162(3):314-327. doi: 10.1111/imm.13286. Epub 2020 Dec 13.
3
Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response.新型三聚体人巨细胞病毒糖蛋白 B 引发高滴度中和抗体反应。
Vaccine. 2018 Sep 5;36(37):5580-5590. doi: 10.1016/j.vaccine.2018.07.056. Epub 2018 Aug 3.
4
HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.巨细胞病毒糖蛋白 B 亚单位疫苗通过非中和抗体效应功能介导的功效。
Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6267-6272. doi: 10.1073/pnas.1800177115. Epub 2018 Apr 30.
5
Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees.血清阴性糖蛋白 B 疫苗接种者获得的人类巨细胞病毒变异株的宿主内动态。
J Virol. 2019 Feb 19;93(5). doi: 10.1128/JVI.01695-18. Print 2019 Mar 1.
6
Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantation.接种巨细胞病毒 gB-MF59 疫苗的血清阴性患者在移植后早期具有针对 gB 的中和抗体反应的证据。
EBioMedicine. 2019 Dec;50:45-54. doi: 10.1016/j.ebiom.2019.11.005. Epub 2019 Nov 15.
7
Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection.在原发性人巨细胞病毒(HCMV)感染具有不同临床表现的免疫功能正常个体中,对HCMV的早期中和及糖蛋白B(gB)特异性抗体反应。
J Clin Virol. 2000 Apr;16(2):113-22. doi: 10.1016/s1386-6532(00)00061-5.
8
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).一种表达巨细胞病毒(CMV)糖蛋白B的金丝雀痘病毒载体可引发针对减毒活CMV疫苗(汤氏疫苗)的抗体反应。
J Infect Dis. 1999 Sep;180(3):843-6. doi: 10.1086/314951.
9
Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.自然感染人巨细胞病毒后针对重组衍生糖蛋白B的抗体与中和活性相关。
J Infect Dis. 1992 Feb;165(2):381-4. doi: 10.1093/infdis/165.2.381.
10
Limited Effector Memory B-Cell Response to Envelope Glycoprotein B During Primary Human Cytomegalovirus Infection.原发性人巨细胞病毒感染期间对包膜糖蛋白B的有限效应记忆B细胞反应
J Infect Dis. 2016 May 15;213(10):1642-50. doi: 10.1093/infdis/jiv769. Epub 2015 Dec 28.

引用本文的文献

1
HCMV carriage in the elderly diminishes anti-viral functionality of the adaptive immune response resulting in virus replication at peripheral sites.在老年人中,CMV 携带会降低适应性免疫反应的抗病毒功能,导致病毒在外周部位复制。
Front Immunol. 2022 Dec 15;13:1083230. doi: 10.3389/fimmu.2022.1083230. eCollection 2022.
2
Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes.人巨细胞病毒(HCMV)中和抗体与 HCMV 糖蛋白复合物抗体的相关性。
Virol J. 2020 Aug 3;17(1):120. doi: 10.1186/s12985-020-01390-2.
3
Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.
人类巨细胞病毒感染、复制和疾病的免疫保护相关因素。
J Infect Dis. 2020 Mar 5;221(Suppl 1):S45-S59. doi: 10.1093/infdis/jiz428.
4
Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees.血清阴性糖蛋白 B 疫苗接种者获得的人类巨细胞病毒变异株的宿主内动态。
J Virol. 2019 Feb 19;93(5). doi: 10.1128/JVI.01695-18. Print 2019 Mar 1.
5
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination.补体增强了针对人巨细胞病毒糖蛋白B(gB)的抗体以及gB/MF59疫苗诱导的免疫血清的体外中和效力。
NPJ Vaccines. 2017 Dec 14;2:36. doi: 10.1038/s41541-017-0038-0. eCollection 2017.
6
A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men.4种重组人巨细胞病毒Towne/Toledo嵌合活疫苗在巨细胞病毒血清学阴性男性中的1期研究。
J Infect Dis. 2016 Nov 1;214(9):1341-1348. doi: 10.1093/infdis/jiw365. Epub 2016 Aug 11.
7
Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.预防先天性巨细胞病毒病疫苗的前景。
Med Microbiol Immunol. 2016 Dec;205(6):537-547. doi: 10.1007/s00430-016-0472-z. Epub 2016 Aug 12.
8
Stanley Plotkin: the bright spark of cytomegalovirus vaccines.斯坦利·普洛特金:巨细胞病毒疫苗的杰出贡献者
Med Microbiol Immunol. 2015 Jun;204(3):243-5. doi: 10.1007/s00430-015-0392-3. Epub 2015 Mar 20.
9
Prevalence of CMV infection among sexually active adolescents: a matched case-control study.性活跃青少年中巨细胞病毒感染的患病率:一项匹配病例对照研究。
Adolesc Health Med Ther. 2014 Apr 29;5:73-8. doi: 10.2147/AHMT.S60103. eCollection 2014.
10
Using the nonhuman primate model of HCMV to guide vaccine development.利用人巨细胞病毒的非人灵长类动物模型来指导疫苗研发。
Viruses. 2014 Mar 27;6(4):1483-501. doi: 10.3390/v6041483.